For the IVK assays, immunocomplexes or GST-fusion proteins expressed in bacteria (see Supplementary Methods) were incubated for 20 min at 30 °C, in the presence or absence of GST-DYRK1A, in 20 µl of phosphorylation buffer (25 mM Hepes [pH 7.4], 5 mM MgCl2, 5 mM MnCl2, 0.5 mM DTT) that contained 50 µM ATP and 2.5 µCi [γ-32P]-ATP (3,000 Ci/mmol, Amersham Biosciences). The incorporation of 32P was determined by SDS-PAGE and exposing the dried gel to film.
DYRK1A kinase activity was assessed using the DYRKtide peptide as the substrate40. Briefly, DYRK1A-immunocomplexes were incubated for 20 min at 30 °C in 20 µl of phosphorylation buffer including 200 µM DYRKtide and 2.5 µCi [γ-32P]-ATP (3,000 Ci/mmol). Aliquots of the reaction were dotted onto P81 Whatman phosphocellulose paper in triplicate, washed extensively with 5% orthophosphoric acid and counted in a liquid scintillation counter (Beckman Coulter).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.